News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
870,837 Results
Type
Article (88033)
Company Profile (825)
Press Release (781957)
Multimedia
Podcasts (198)
Webinars (28)
Section
Business (233296)
Career Advice (4147)
Deals (39885)
Drug Delivery (151)
Drug Development (91436)
Employer Resources (205)
FDA (18402)
Job Trends (17430)
News (397981)
Policy (39976)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3014)
Academic (2)
Accelerated approval (34)
Adcomms (36)
Allergies (149)
Alliances (56982)
ALS (182)
Alzheimer's disease (1801)
Antibody-drug conjugate (ADC) (351)
Approvals (18586)
Artificial intelligence (635)
Autoimmune disease (168)
Automation (39)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (490)
Bladder cancer (164)
Brain cancer (65)
Breast cancer (672)
Cancer (5095)
Cardiovascular disease (451)
Career advice (3572)
Career pathing (41)
CAR-T (307)
CDC (59)
Celiac Disease (2)
Cell therapy (840)
Cervical cancer (38)
Clinical research (77101)
Collaboration (1844)
Company closure (5)
Compensation (1184)
Complete response letters (73)
COVID-19 (2994)
CRISPR (99)
C-suite (883)
Cystic fibrosis (155)
Data (6347)
Decentralized trials (2)
Denatured (73)
Depression (152)
Diabetes (537)
Diagnostics (7244)
Digital health (48)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (305)
Drug pricing (227)
Drug shortages (36)
Duchenne muscular dystrophy (243)
Earnings (100239)
Editorial (65)
Employer branding (25)
Employer resources (173)
Events (135224)
Executive appointments (1034)
FDA (21626)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1570)
Gene editing (218)
Generative AI (67)
Gene therapy (679)
GLP-1 (1140)
Government (5451)
Grass and pollen (8)
Guidances (387)
Healthcare (20954)
HIV (63)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (297)
Immuno-oncology (62)
Indications (105)
Infectious disease (3284)
Inflammatory bowel disease (207)
Inflation Reduction Act (17)
Influenza (121)
Intellectual property (252)
Interviews (816)
IPO (17963)
IRA (60)
Job creations (5200)
Job search strategy (2866)
JPM (70)
Kidney cancer (17)
Labor market (94)
Layoffs (660)
Leadership (40)
Legal (10161)
Liver cancer (99)
Longevity (16)
Lung cancer (684)
Lymphoma (383)
Machine learning (45)
Management (66)
Manufacturing (866)
MASH (175)
Medical device (15046)
Medtech (15102)
Mergers & acquisitions (23000)
Metabolic disorders (1418)
Multiple sclerosis (169)
NASH (23)
Neurodegenerative disease (359)
Neuropsychiatric disorders (103)
Neuroscience (3144)
Neurotech (1)
NextGen: Class of 2026 (7709)
Non-profit (5113)
Now hiring (66)
Obesity (690)
Opinion (337)
Ovarian cancer (169)
Pain (218)
Pancreatic cancer (234)
Parkinson's disease (303)
Partnered (39)
Patents (514)
Patient recruitment (495)
Peanut (60)
People (66955)
Pharmaceutical (145)
Pharmacy benefit managers (33)
Phase 1 (23824)
Phase 2 (33458)
Phase 3 (25206)
Pipeline (5266)
Policy (340)
Postmarket research (3554)
Preclinical (10695)
Press Release (72)
Prostate cancer (251)
Psychedelics (57)
Radiopharmaceuticals (303)
Rare diseases (928)
Real estate (7442)
Recruiting (80)
Regulatory (29099)
Reports (67)
Research institute (2729)
Resumes & cover letters (651)
Rett syndrome (28)
RNA editing (21)
RSV (85)
Schizophrenia (160)
Series A (261)
Series B (199)
Service/supplier (30)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (178)
Sponsored (48)
Startups (4334)
State (2)
Stomach cancer (20)
Supply chain (114)
Tariffs (101)
The Weekly (123)
Vaccines (1151)
Venture capital (98)
Weight loss (476)
Women's health (92)
Worklife (22)
Date
Today (51)
Last 7 days (656)
Last 30 days (2192)
Last 365 days (32760)
2026 (3148)
2025 (33230)
2024 (38141)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1290)
Alabama (92)
Alaska (7)
Arizona (344)
Arkansas (14)
Asia (51593)
Australia (9063)
California (11664)
Canada (3349)
China (1185)
Colorado (495)
Connecticut (505)
Delaware (351)
Europe (118542)
Florida (1715)
Georgia (375)
Hawaii (4)
Idaho (68)
Illinois (974)
India (70)
Indiana (547)
Iowa (24)
Japan (436)
Kansas (133)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1464)
Massachusetts (8580)
Michigan (363)
Minnesota (669)
Mississippi (6)
Missouri (140)
Montana (35)
Nebraska (29)
Nevada (127)
New Hampshire (86)
New Jersey (3130)
New Mexico (33)
New York (3080)
North Carolina (1624)
North Dakota (10)
Northern California (5593)
Ohio (357)
Oklahoma (23)
Oregon (55)
Pennsylvania (2325)
Puerto Rico (23)
Rhode Island (50)
South America (1664)
South Carolina (67)
South Dakota (1)
Southern California (4506)
Tennessee (177)
Texas (1841)
United States (42055)
Utah (351)
Vermont (1)
Virginia (292)
Washington D.C. (88)
Washington State (984)
West Virginia (4)
Wisconsin (131)
Wyoming (2)
There are 870,837 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
UK-Based Vesalic Limited Emerges from Stealth with Landmark Discovery of Potential Non-CNS Driver of Motor Neuron Diseases, including ALS, and Breakthrough Therapeutic and Diagnostic Opportunities
February 9, 2026
·
8 min read
Press Releases
InnoCare Announces IND Approval to Initiate Clinical Trial of VAV1 Degrader ICP-538 in China
February 9, 2026
·
2 min read
Press Releases
Biologics License Application for Subcutaneous Formulation of “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer’s Disease Designated for Priority Review in China
February 9, 2026
·
12 min read
Press Releases
Innovent Announces Strategic Collaboration with Lilly to Develop New Medicines Globally in Oncology and Immunology
February 9, 2026
·
4 min read
Press Releases
Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)
February 9, 2026
·
17 min read
Press Releases
Public Advisory - Two lots of MAR-Amlodipine 5 mg tablets recalled as some bottles may contain the wrong drug
February 9, 2026
·
3 min read
Press Releases
Roche’s fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)
February 9, 2026
·
10 min read
Press Releases
Johnson & Johnson Presents Early Outcomes from the OMNY-AF Pilot Study at 2026 AF Symposium
February 9, 2026
·
10 min read
Press Releases
Geneoscopy Wins Second Patent Trial and Appeal Board Decision, Invalidating All Challenged Claims of Exact Sciences’ ’746 Patent
February 9, 2026
·
3 min read
Press Releases
Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement
February 9, 2026
·
5 min read
1 of 87,084
Next
